Sevoflurane and desflurane concentration for the removal of the ProSeal Laryngeal Mask Airway
Phase 3
Completed
- Conditions
- Health Condition 1: null- cervical carcinomaHealth Condition 2: N879- Dysplasia of cervix uteri, unspecified
- Registration Number
- CTRI/2012/12/003250
- Lead Sponsor
- Post Graduate Institute of Medical Education and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Female patients of ASA status 1â??2 and aged 18-60 years, undergoing intracavity implant of caesium for cervical carcinoma under general anaesthesia
Exclusion Criteria
Body mass index greater than 35 kg/m2, cervical spine disease, a known difficult airway, mouth opening less than 2.5 cm, upper respiratory tract symptoms in the previous 10 days, or if the patient considered at risk of aspiration (nonfasted, gastrosophageal reflux disease).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The ED50 of Sevoflurane and Desflurane for successful PLMA removal.Timepoint: At or one minute after PLMA removal
- Secondary Outcome Measures
Name Time Method success rate of PLMA removal, emergence time, incidence of coughing, clenching of teeth, complications and manoeuvre used to relieve airway obstruction.Timepoint: At or one minute after PLMA removal